---
figid: PMC9077305__JCMM-26-2607-g005
pmcid: PMC9077305
image_filename: JCMM-26-2607-g005.jpg
figure_link: /pmc/articles/PMC9077305/figure/jcmm17267-fig-0006/
number: FIGURE 6
figure_title: ''
caption: Schematic mechanism of periplocymarin (PM) in the treatment of pathological
  cardiac hypertrophy
article_title: Periplocymarin alleviates pathological cardiac hypertrophy via inhibiting
  the JAK2/STAT3 signalling pathway.
citation: Cai‐lian Fan, et al. J Cell Mol Med. 2022 May;26(9):2607-2619.
year: '2022'

doi: 10.1111/jcmm.17267
journal_title: Journal of Cellular and Molecular Medicine
journal_nlm_ta: J Cell Mol Med
publisher_name: John Wiley and Sons Inc.

keywords:
- JAK2/STAT3 signalling pathway
- pathological cardiac hypertrophy
- periplocymarin

---
